LT - TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY
EN - TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
C07K 16/30 |
|
|
|
C07K 14/705 |
|
|
|
C07K 14/725 |
|
|
|
A61K 35/17 |
|
|
|
A61P 35/00 |
|
|
|
C07K 19/00 |
|
European patent
(11) |
Number of the document |
3189073 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
15757289.2 |
|
Date of filing the European patent application |
2015-09-03 |
(97) |
Date of publication of the European application |
2017-07-12 |
(45) |
Date of publication and mention of the grant of the patent |
2019-12-25
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/EP2015/070128 |
|
Date |
2015-09-03 |
PCT application publication
(87) |
Number |
WO 2016/034666 |
|
Date |
2016-03-10 |
Priority applications
(30) |
Number |
Date |
Country code |
|
201470543 |
2014-09-04
|
DK |
Inventors
(72) |
SCHIFFER-MANNIOUI, Cčcile, FR
|
Grantee
(73) |
Cellectis,
8, rue de la Croix Jarry, 75013 Paris,
FR
|
Title
(54) |
TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY |
|
TROPHOBLAST GLYCOPROTEIN (5T4, TPBG) SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY |